1643 — Modern Chinese Medicine Co Income Statement
0.000.00%
- HK$240.00m
- -HK$67.49m
- CNY344.08m
- 61
- 84
- 30
- 63
Annual income statement for Modern Chinese Medicine Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 219 | 309 | 361 | 400 | 344 |
Cost of Revenue | |||||
Gross Profit | 99.1 | 137 | 158 | 171 | 104 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 154 | 218 | 246 | 275 | 276 |
Operating Profit | 65.3 | 90.7 | 114 | 124 | 68.3 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 65.3 | 90.5 | 114 | 124 | 68.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 46.2 | 63.6 | 81.8 | 87.8 | 48.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 46.2 | 63.6 | 81.8 | 87.8 | 48.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 46.2 | 63.6 | 81.8 | 87.8 | 48.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.091 | 0.123 | 0.138 | 0.146 | 0.081 |
Dividends per Share |